Adverse events1,408

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 1,408

Type	Event	Organ system	Group	Affected	At risk
other	Anaemia	Blood and lymphatic system disorders	Dose-escalation Cohort 1: Placebo	0	11
other	Anaemia	Blood and lymphatic system disorders	Dose-escalation Cohort 1: Omecamtiv Mecarbil 25 mg M-F1	0	10
other	Anaemia	Blood and lymphatic system disorders	Dose-escalation Cohort 1: Omecamtiv Mecarbil 25 mg M-F2	0	14
other	Anaemia	Blood and lymphatic system disorders	Dose-escalation Cohort 1: Omecamtiv Mecarbil 25 mg SCT-F2	0	13
other	Anaemia	Blood and lymphatic system disorders	Dose-escalation Cohort 2: Placebo	1	10
other	Anaemia	Blood and lymphatic system disorders	Dose-escalation Cohort 2: Omecamtiv Mecarbil 50 mg M-F1	0	11
other	Anaemia	Blood and lymphatic system disorders	Dose-escalation Cohort 2: Omecamtiv Mecarbil 50 mg M-F2	0	11
other	Anaemia	Blood and lymphatic system disorders	Dose-escalation Cohort 2: Omecamtiv Mecarbil 50 mg SCT-F2	0	14
other	Anaemia	Blood and lymphatic system disorders	Expansion Phase: Placebo	1	149
other	Anaemia	Blood and lymphatic system disorders	Expansion Phase: Omecamtiv Mecarbil 25 mg	0	150
other	Anaemia	Blood and lymphatic system disorders	Expansion Phase: OM PK-based Titration	0	146
other	Bundle branch block left	Cardiac disorders	Dose-escalation Cohort 1: Placebo	0	11
other	Bundle branch block left	Cardiac disorders	Dose-escalation Cohort 1: Omecamtiv Mecarbil 25 mg M-F1	1	10
other	Bundle branch block left	Cardiac disorders	Dose-escalation Cohort 1: Omecamtiv Mecarbil 25 mg M-F2	0	14
other	Bundle branch block left	Cardiac disorders	Dose-escalation Cohort 1: Omecamtiv Mecarbil 25 mg SCT-F2	0	13
other	Bundle branch block left	Cardiac disorders	Dose-escalation Cohort 2: Placebo	0	10
other	Bundle branch block left	Cardiac disorders	Dose-escalation Cohort 2: Omecamtiv Mecarbil 50 mg M-F1	0	11
other	Bundle branch block left	Cardiac disorders	Dose-escalation Cohort 2: Omecamtiv Mecarbil 50 mg M-F2	0	11
other	Bundle branch block left	Cardiac disorders	Dose-escalation Cohort 2: Omecamtiv Mecarbil 50 mg SCT-F2	0	14
other	Bundle branch block left	Cardiac disorders	Expansion Phase: Placebo	0	149

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNone stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01786512/events

API reference For AI assistants

Adverse events1,408

Sources 3

Read this list from software.